false
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Catalog
2024 Congenital Coding Update
Introduction
Introduction
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Welcome, everybody, for joining the SCAI coding webinar for congenital heart disease. This is our fifth one so far. Before we start, I just want to introduce the panelists here. We have Mark Hoyer from Indiana Riley Children's, Sean Batlavala from Cincinnati Children's, Guru Hiramath from the University of Minnesota, Jeremy Ringwell from St. Joseph Children's in Tampa, Nicole Sutton from Montefiore, New York, and then we also have a new member who's joined our group from Children's of Nebraska, that's Chris Curzon, and then Alan Nguyen is our SCAI liaison who's helping us coordinate. We have a packed hour for coding information, and Mark's going to start off with talking over the 2024 codes and then also some of the new efforts that will happen in 2025, and then followed by six different questions or topics that we've gathered from over the year from different people who've submitted these questions, and so the topics are going to be sort of trying to answer some of these important questions. Sean's going to talk about normal versus abnormal connections. Chris is going to talk about cardiac transplant catheterizations, congenital versus non-congenital. Guru Hiramath was focused on intracardiac stents, hybrid single ventricle interventions, followed by Jeremy Ringwell, who's going to speak a little bit about the transcatheter PDA stenting and then PA stenting. Nicole will go over the coarctation stents, particularly when it crosses side branching because that can be confusing, and I'll end it with going over some of the modifiers of codes that are useful. Okay. Now, just bear in mind, everybody, that congenital heart disease coding is not a perfect science, and there are many gray areas. Sometimes we ourselves don't always agree, but there will always be one case in which the descriptions, no interventions, there's just no good description for that unique intervention, but as a workgroup, we've done our best to adjudicate the questions, and we will be discussing those today. Stents do represent the agreement with the group, even though there may be some exceptions to the rule. Feel free to send emails with specific questions. So without any more delay, we're going to take these questions, and even if we don't have time to answer them today, we'll get back to you guys. So without any more delay, Mark, why don't you take us off with your presentation?
Video Summary
The transcript is from a coding webinar on congenital heart disease. The panelists include medical professionals from various hospitals discussing different coding topics related to heart conditions. They cover a variety of topics such as normal versus abnormal connections, cardiac transplant catheterizations, stents, and modifiers of codes. The panel acknowledges the challenges of coding for congenital heart disease, as it is not always straightforward and may have grey areas. They encourage viewers to email specific questions for further discussion. Each panelist will address specific topics related to coding, aiming to provide clarity on complex interventions.
Asset Subtitle
Frank Ing, MD, MSCAI
Keywords
congenital heart disease
coding webinar
cardiac transplant catheterizations
stents
modifiers of codes
×